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Background. Malaria transmission through blood transfusion is an accidental but preventable cause of malaria infection and is 
increasingly becoming a matter of concern for blood transfusion services. This systematic review was conducted to provide a sum-
mary of evidence about the prevalence of Plasmodium infection in asymptomatic blood donors and the effectiveness of screening 
methods used based on the available literature. 
Methods. PRISMA guidelines were followed. Scopus, PubMed, Science Direct, and EMBASE were searched from 1982 to 
October 10, 2017. All peer-reviewed original research articles describing the prevalence of malaria parasitemia in blood donors with 
different diagnostic methods were included. The random-effects model was applied to assess the effects of heterogeneity among the 
selected studies. Incoherence and heterogeneity between studies were quantified by I2 index and Cochran’s Q test. Publication and 
population bias was assessed with funnel plots and Egger’s regression asymmetry test. All statistical analyses were performed using 
Stata (version 2.7.2).
Results. Seventy-one studies from 21 countries, 5 continents, were included in the present systematic review. The median prev-
alence of malaria parasitemia among 984 975 asymptomatic healthy blood donors was 10.54%, 5.36%, and 0.38% by microscopy, 
molecular methods (polymerase chain reaction), and rapid diagnostic tests, respectively. The most commonly detected Plasmodium 
species was P. falciparum.
Conclusions. This systematic review demonstrates that compared with other transfusion-linked infections, that is, HIV, HCV, 
and HBV, transfusion-transmitted malaria is one of the most significant transfusion-associated infections especially in Sub-Saharan 
Africa. Future work must aim to understand the clinical significance of transfusion-transmitted malaria in malaria-endemic settings. 
Keywords. blood donor; Plasmodium; systematic review; transfusion-associated infections; transfusion medicine.
Approximately 3.3 billion of the world’s population resides in 
malaria-endemic regions, and of those, 1.2 billion are at high 
risk of malaria infection [1, 2]. Malaria often affects the most 
vulnerable, notably young children and pregnant women in 
the developing world, leading to significant morbidity and 
mortality [3]. Although malaria is usually transmitted by 
Plasmodium parasite’s vector female Anopheles mosquitos [2, 4], 
it is also readily transmitted through blood transfusion [5–8], 
organ transplantation, and needle stick injury [9].
Transfusion-transmitted malaria (TTM) is one of the first 
recorded incidents of transfusion-associated infection [10]. 
It is an incidental transmission of Plasmodium parasite from 
an asymptomatic donor with parasitemia to a blood recip-
ient and is a significant concern, especially in nonendemic 
areas. Plasmodium parasites were shown to survive in whole 
blood and plasma when stored at 4°C for approximately up 
to 18  days, and detectable parasites can present even up to 
28  days when frozen, although with diminished infectivity 
[11, 12]. Some population-based studies and systematic 
reviews have examined the prevalence of malaria infection in 
blood donors in developed, nonendemic countries [2, 5–7], 
but a knowledge gap still exists in regard to the extent and 
dynamics of malaria infection in blood donors, especially in 
malaria-endemic areas [13, 14].
Malaria is caused by a unicellular apicomplexan called 
Plasmodium, and 5 species are known to cause disease in 
humans: P.  falciparum, P.  vivax, P.  malariae, P.  ovale, and 
P. knowlesi [4, 15–17]. In TTM, the most common Plasmodium 
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species observed were P.  falciparum, followed by P.  malariae, 
P.  vivax, and P.  ovale [6, 8]. According to a systematic re-
view, the incubation period for TTM was found to be longer 
compared with natural mosquito-transmitted malaria infection 
[8]. The primary concern in regard to TTM compared with nat-
ural infection is that the patients infected through transfusion 
may present late with severe complications due to the imme-
diate release of parasites [18]. This could lead to fatal outcomes 
in children, the elderly, and patients who are pregnant or 
immunosuppressed.
This systematic review and meta-analysis was performed (1) 
to provide a summary of the evidence to understand the preva-
lence of Plasmodium infection in the asymptomatic blood donor 
population based on the available literature, (2) to compare the 
effectiveness of screening methods used to detect malaria par-
asitemia in blood donors, and (3) to identify risk factors asso-
ciated with active malaria infection in the asymptomatic blood 
donor population.
METHODS
This systematic review was performed in accordance with the 
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines [19].
Search Strategy
We retrieved all articles on malaria infection among the 
blood donor population through systematic searches of major 
databases such as PubMed, EMBASE, Scopus, and Web of 
Science from 1982 to October 10, 2017, using Medical Subject 
Headings (MeSH) terms, including “malaria,” “Plasmodium,” 
“prevalence,” “epidemiology,” “blood donors,” “transfusion,” 
“transplant recipients,” and “blood pack” alone or combined to-
gether using “OR” and/or “AND.”
Study Selection
Studies were eligible if they met the inclusion criteria: (1) peer-
reviewed original research articles; (2) cross-sectional studies 
that estimated the prevalence of malaria infection in blood 
donors with different diagnostic methods including micros-
copy, rapid diagnostic testing (RDT), and molecular techniques 
(polymerase chain reaction [PCR]); (3) published papers 
in English; (4) published papers in other languages with an 
English abstract; (5) published online from 1982 to October 10, 
2017. We also manually screened the references of the included 
original studies, and reviews were conducted for obtaining ad-
ditional studies.
Data Extraction
Two authors (M.F. and S.M.) screened references and retrieved 
articles according to the eligibility criteria. Disagreements were 
resolved through discussion and consensus. Any study that did 
not match the eligibility criteria was excluded. Two reviewers 
independently assessed the quality and performed the final ar-
ticle selection. From each study, the following variables were 
extracted: the name of the first author, year of publication, 
country, sample size, number of positive samples, diagnostic 
methods used (microscopy, RDT, or molecular methods), risk 
factors such as residence, gender, number of blood donations 
(the first or repeat donation), type of donors (voluntary, re-
placement/family, or commercial), and blood group.
Meta-analysis
For every study included, the point estimate and 95% confi-
dence interval (CI) were calculated. The random-effects model 
(DerSimonian or Laird) was applied to assess the effects of het-
erogeneity among the selected studies. Forest plots provided a 
detailed representation of all studies based on the effect sizes 
and 95% CIs. Incoherence and heterogeneity between studies 
were quantified using the I2 index and Cochran’s Q test, respec-
tively. Heterogeneity among subgroups and the relationship 
between prevalence, year of publication, and sample size were 
estimated using metaregression. Publication and population 
bias were assessed with funnel plots and the Egger’s regression 
asymmetry test. All statistical analyses were performed using 
Stata (version 2.7.2).
RESULTS
The systematic search identified 1123 potentially relevant arti-
cles. Two hundred forty-one articles were retrieved for more de-
tailed evaluation and assessed for eligibility. After reviewing the 
eligibility criteria, a total of 71 studies conducted in 21 countries 
and 5 continents were included in this meta-analysis. The num-
bers of selected papers at each step of screening and eligibility 
are reported in the flow diagram (Figure 1).
Baseline characteristics of all studies included in this analysis 
are shown in the Supplementary Data. Three types of diagnostic 
methods were used to detect the prevalence of malaria in the in-
cluded studies: microscopy (n = 51), RDT (n = 25), and molec-
ular techniques (n = 14) (Supplementary Tables 1–3). A total of 
984 975 blood samples were examined for malaria infection in 
all studies: 374 919 samples by microscopy, 604 693 by RDT in-
cluding immunochromatographic test, and 5363 by molecular 
techniques (PCR, real-time PCR, PCR-restriction fragment 
length polymorphism (RFLP) and nested PCR). The pooled 
proportion of malaria prevalence among the blood donor pop-
ulation was 10.54% (95% CI, 8.44%–12.84%) by microscopy, 
5.36% (95% CI, 2.25%–9.70%) by PCR, and 0.38% (95% CI, 
0.25%–0.54%) by RDT (Figures 2–4).
We then compared studies according to the publication year, 
categorizing studies into those published before 2010 (n = 31) 
and after 2010 (n = 20) to provide a recent estimate of the prev-
alence by microscopy in this population. The pooled prevalence 
of malaria infection in asymptomatic blood donors was 7.14% 
(95% CI, 3.61%–11.74%) among studies conducted before 2010 
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vs 13.61% (95% CI, 9.33%–18.55%) among those conducted 
after 2010. Although we observed a difference in prevalence, 
this was not statistically significant (P = .1872).
Continents Subgroup Analysis
A subgroup analysis of the malaria prevalence among the blood 
donor population in different continents was conducted (Table 
1). The highest prevalence of malaria infection among blood 
donors was observed in Africa; 21% (95% CI,  14%–29%) of 
blood donors had a positive malaria test detected by micros-
copy. By RDT, the highest prevalence was observed in Africa 
(7.4%; 95% CI, 3%–12%), and no parasitemia was detected in 
other continents. Molecular methods (PCR) have indicated a 
higher prevalence of malaria infection in the blood donor pop-
ulation in Africa (36%; 95% CI, 11%–72%). However, using a 
molecular technique did not impact the observed prevalence 
in other continents: Asia 4% (95% CI, 1%–13%), Americas 2% 
(95% CI, 1%–7%), and Europe 1% (95% CI, 0%–3%).
As shown in Figure 5, Nigeria had the highest estimated 
prevalence of malaria infection among blood donors (31.7%), 
followed by Ghana (19.4) and Sudan (17%). Turkey and China 
had the lowest estimated prevalence of malaria infection among 
blood donors. Publication bias detection using Egger’s regres-
sion indicated bias in the case of microscopy (P < .0001), RDTs 
(P = .04), and PCR (P = .01) studies.
Risk Factors
According to the multivariate analysis, a positive associa-
tion was observed between malaria infection and female 
sex, commercial donor type, and blood group A  (P  <  .005). 
Those individuals residing in rural areas and with no his-
tory of previous transfusion had a higher prevalence of infec-
tion; however, this were not statistically significant. Detailed 
characteristics of the associated risk factors are displayed in 
Supplementary Table 4.
DISCUSSION
This systematic review and meta-analysis provide comprehen-
sive data on the prevalence of malaria in the asymptomatic 
blood donor population. The median worldwide prevalence of 
malaria parasitemia in healthy blood donors was 10.54% (95% 
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Figure 1. Flowchart describing the study design process.
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CI, 8.44%–12.84%) by microscopy, 5.36% (95% CI, 2.25%–
9.70%) by molecular techniques, and 0.38% (95% CI, 0.25%–
0.54%) by RDTs.
The overall prevalence of malaria in blood donors was, 
expectedly, higher in Africa compared with the other continents, 
and the highest prevalence was observed in Nigeria. Although 
Proportion meta-analysis plot [random eects]
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Figure 2. Forest plot diagram of the studies reporting malaria prevalence among blood donors by microscopy.
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it is not surprising to observe high prevalence in Nigeria given 
that it is one of the most malaria-affected countries [1], prima-
rily due to the increased number of vector mosquitos, socioec-
onomic conditions, and favorable climate [20–22], worryingly 
one-third of healthy donors by microscopy were found to be 
malaria-infected. This emphasizes that TTM is one of the most 
significant transfusion-associated infections in Sub-Saharan 
Africa compared with other infections such as HIV, hepatitis 
C, and hepatitis B, where the prevalence ranges from 0.5% 
to 16%, 0.5% to 3%, and 5% to 25%, respectively [23]. These 
findings have several implications: (1) although significant sci-
entific progress has been made in blood donation screening, 
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Figure 3. Forest plot diagram of studies reporting malaria prevalence among blood donors based on immunochromatographic rapid testing (rapid diagnostic test and 
immunochromatographic test).
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TTM remains a potential risk for blood transfusion recipients; 
(2) infected recipients who do not manifest clinical disease may 
become asymptomatic carriers and thus constitute a reservoir 
of malaria parasites if competent vectors are transmitted; (3) the 
incident may lead to serious consequences, especially among 
vulnerable patients (the elderly, children, those who are immu-
nosuppressed, and pregnant women) and in nonendemic coun-
tries where most people have never been exposed to malaria.
Table 1.  Subgroup Analysis of Malaria Prevalence in Different Continents
Continent No. of Studies Type of Study Prevalence (95% CI) I2, %
Heterogeneity Egger Test
Q P Value T P Value
Africa 33 Microscopy 0.21 (0.14–0.29) 99 3299.3 <.0001 9.5 P < .0001
2 PCR 0.36 (0.11–0.72) 96 25.8 <.01 - -
7 RDT 0.074 (0.03–0.12) 95.8 142.04 <.0001 5.5 .02
America 1 Microscopy 0 - - - - -
4 PCR 0.02 (0.01–0.07) 93 65.5 <.01 13.3 .21
Asia 14 Microscopy 0.005 (0.01–0.05) 98 333.1 <.01 2.1 .04
5 PCR 0.04 (0.01–0.13) 85 34.9 <.01 2.3 .5
15 RDT 0.00 (0.00–0.00) 97.5 550.8 <.0001 3.34 .0063
Europe 3 Microscopy 0.00 (0.00–0.00) 34 - .22 - .01
3 PCR 0.01 (0.00–0.03) 54 4.1 .11 - -
3 RDT 0.00 (0.00–0.00) 0 0.59 .74 - -
Abbreviations: CI, confidence interval; PCR, polymerase chain reaction; RDT, rapid diagnostic testing.
Proportion meta-analysis plot [random eects]
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Figure 4. Forest plot diagram of the studies reporting malaria prevalence among blood donors based on molecular techniques.
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Blood donor selection and deferral instructions are the initial 
fundamental steps in ensuring safety and preventing transfusion-
transmissible infections. Understanding risk factors and the timing 
of the disease is key in the donor selection process. Self-reported 
history and risk factors associated with malaria infection in rela-
tion to residence or travel to malaria-endemic areas are used as 
part of a primary donor screening tool in nonendemic areas [24]. 
However, screening tools developed for nonendemic countries are 
not applicable to malaria-endemic areas. Similarly, although the 
majority of blood recipients in malaria-endemic areas are exposed 
to malaria, the degree of immunity this provides and the clinical 
impact of TTM in these settings are unknown. Given that the ma-
jority of blood recipients in low- and middle-income countries are 
children and pregnant women [23] and only a few parasites in a 
unit of blood are enough to cause infection in exposed individuals 
[18], international guidelines recommend malaria screening 
in blood donors [25]. The World Health Organization (WHO) 
guidelines on blood donor selection emphasize the importance of 
implementing screening tools tailored to the local context for all 
transfusion-transmissible infections including malaria [25]. Given 
the wide variation of malaria prevalence in donors, it is essential for 
each country to define the donor population with a high risk of in-
fection and establish donor selection criteria. A geographical model 
for TTM displaying prevalence of malaria infection among blood 
donors could easily be incorporated into this primary screening 
tool. Our meta-analysis indicates that healthy donors with certain 
risk factors have increased odds of having malaria infection, such 
as being a commercial donor, residence in an urban area, and first 
blood transfusion. It is important to note that in the subgroup anal-
ysis, the majority of studies reporting prevalence in urban vs rural 
donors included donors residing in urban settings, which might 
have influenced this observation. Identification of risk factors nev-
ertheless may help to narrow down donor selection criteria, par-
ticularly in countries where there is no agreed-upon framework to 
screen all donations for parasitemia. Exclusion of malaria-positive 
or high-risk blood donors may not be feasible in some settings due 
to the high demand for blood transfusion. In areas with high prev-
alence of malaria infection, clear donor deferral instructions could 
nevertheless be implemented to ensure continuous blood supply.
An important caveat for determining the actual burden of 
Plasmodium infection in the blood donor population and ac-
cordingly understanding the risk of TTM is to detect low-level 
parasitemia. Additionally, there is very limited evidence to in-
form which malaria screening methods are effective for use by 
transfusion services in malaria-endemic settings. Although the 
microscopic diagnosis is the gold standard technique [26], in 
recent years, molecular methods such as PCR have been devel-
oped, providing increased sensitivity [27]. We observed lower 
prevalence detected by molecular techniques compared with mi-
croscopy. The difference observed in prevalence might be due to 
the differences in the studies included; only 14 studies reported 
prevalence among blood donors using molecular techniques, 
the majority of which were conducted in malaria-nonendemic 
countries. Although PCR is the most sensitive and possibly ideal 
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Figure 5. Overall malaria prevalence among asymptomatic blood donors in different geographical regions.
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screening method for malaria infection in the blood donor pop-
ulation, due to the costs involved and expertise required, mo-
lecular methods cannot easily be implemented in every setting. 
RDTs are an alternative where good quality services are not 
readily available [28]. Serological tests can also be applied to 
detect malaria antibodies for screening blood donors, with the 
caveat that a positive test does not necessarily indicate active in-
fection, and the majority of residents in endemic areas would 
have antimalarial antibodies, so serologic tests are likely un-
helpful for screening blood donors in malaria-endemic settings 
[24, 29]. Therefore, a combination of different approaches needs 
to be consolidated to ensure the safety of blood transfusions by 
screening with a diagnostic technique that is sensitive enough to 
detect low-level parasitemia, taking into consideration the costs 
and the laboratory personnel expertise obtainable in a given 
setting.
This meta-analysis has several strengths. First, this is the first 
study examining the global epidemiology of malaria infection in 
the asymptomatic blood donor population. Second, we reported 
differences in the prevalence of malaria infection according to 
the screening methods used in studies. In contrast, the most im-
portant study limitation relates to the inherent nature of system-
atic reviews, based on differences in the studies included in this 
review; that is, the methodology, quality, different diagnostics 
tests with variable sensitivity and specificity used in various 
studies, and data on the malaria prevalence are not available in 
many parts of the world.
CONCLUSIONS
This systematic review demonstrates that TTM is one of the most 
significant transfusion-associated infections, especially in Sub-
Saharan Africa, compared with other transfusion-linked infections. 
World Health Organization guidelines for screening and deferral 
need to be reinforced in each country and tailored to the local con-
text. Future work must aim to understand the clinical significance 
of transfusion-transmitted malaria in malaria-endemic settings.
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